April 2025
1. LEE YC
   Single-biopsy epigenetic profiling reveals persistent DNA methylation and gastric cancer risk after Helicobacter pylori eradication.
   Gut. 2025 Apr 23:gutjnl-2025-335329. doi: 10.1136/gutjnl-2025-335329.
   

   >> Share

   
   October 2024
2. OLMEDO L, Calvet X, Gene E, Bordin DS, et al
   Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg).
   Gut. 2024 Oct 26:gutjnl-2024-332804. doi: 10.1136/gutjnl-2024-332804.
   

   >> Share

   
   August 2024
3. LIU Z, Hong J, He F
   Letter to the editor: Autoimmune gastritis may be less susceptible to cancer development than Helicobacter pylori-related gastritis based on histological analysis.
   Gut. 2024 Aug 29:gutjnl-2024-333604. doi: 10.1136/gutjnl-2024-333604.
   

   >> Share

   
   July 2024
4. ZHANG Q, Dunbar KB, Odze RD, Agoston AT, et al
   Hypoxia-inducible factor-1alpha mediates reflux-induced epithelial-mesenchymal plasticity in Barrett's oesophagus patients.
   Gut. 2024;73:1269-1279.
   

   >> Share

   
   June 2024
5. GAO W, Liu J, Wang X, Li J, et al
   Simplified Helicobacter pylori therapy for patients with penicillin allergy: a randomised controlled trial of vonoprazan-tetracycline dual therapy.
   Gut. 2024 Jun 21:gutjnl-2024-332640. doi: 10.1136/gutjnl-2024-332640.
   

   >> Share

   
   May 2024
6. YUAN S, Larsson SC, Gill D, Burgess S, et al
   Concerns about instrumental variable selection for biological effect versus uptake of proton pump inhibitors in Mendelian randomisation analysis.
   Gut. 2024 May 2:gutjnl-2024-332280. doi: 10.1136/gutjnl-2024-332280.
   

   >> Share

   
   April 2024
7. DUTTA AK, Sharma V, Jain A, Elhence A, et al
   Inappropriate use of proton pump inhibitors in clinical practice globally: a systematic review and meta-analysis.
   Gut. 2024 Apr 26:gutjnl-2024-332154. doi: 10.1136/gutjnl-2024-332154.
   

   >> Share

   
   March 2024
8. BOECKXSTAENS G, Elsen S, Belmans A, Annese V, et al
   10-year follow-up results of the European Achalasia Trial: a multicentre randomised controlled trial comparing pneumatic dilation with laparoscopic Heller myotomy.
   Gut. 2024;73:582-589.
   

   >> Share

   
   February 2024
9. AN H, Zhong M, Gan H
   Proton pump inhibitors and the risk of inflammatory bowel disease: a Mendelian randomisation study.
   Gut. 2024 Feb 15:gutjnl-2024-331904. doi: 10.1136/gutjnl-2024-331904.
   

   >> Share

   
   January 2024
10. XIAO X, Zhang X, Wang J, Liu Y, et al
    Proton pump inhibitors alter gut microbiota by promoting oral microbiota translocation: a prospective interventional study.
    Gut. 2024 Jan 24:gutjnl-2023-330883. doi: 10.1136/gutjnl-2023-330883.
    

    >> Share

    
    
11. BLACK CJ, Paine PA, Ford AC
    Letter to the editor: Helicobacter pylori eradication, the proof is not in the symptoms-authors' reply.
    Gut. 2024 Jan 12:gutjnl-2024-331892. doi: 10.1136/gutjnl-2024-331892.
    

    >> Share

    
    December 2023
12. NARENDREN A, Tsoi AH, Iqbal A, Glance S, et al
    Rare complication of peptic ulcer disease.
    Gut. 2023 Dec 12:gutjnl-2023-330867. doi: 10.1136/gutjnl-2023-330867.
    

    >> Share

    
    
13. TOH DE, Lo SW, Tsoi A, Segal JP, et al
    Right tool for the right bleeder.
    Gut. 2023;73:206-207.
    

    >> Share

    
    November 2023
14. ZHU J, Sun C, Li M, Hu G, et al
    Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial.
    Gut. 2023 Nov 22:gutjnl-2023-330168. doi: 10.1136/gutjnl-2023-330168.
    

    >> Share

    
    
15. LUO S, Ru J, Khan Mirzaei M, Xue J, et al
    Helicobacter pylori infection alters gut virome by expanding temperate phages linked to increased risk of colorectal cancer.
    Gut. 2023 Nov 2:gutjnl-2023-330362. doi: 10.1136/gutjnl-2023-330362.
    

    >> Share

    
    September 2023
16. LIU BD, Udemba SC, Liang K, Tarabichi Y, et al
    Shorter-acting glucagon-like peptide-1 receptor agonists are associated with increased development of gastro-oesophageal reflux disease and its complications in patients with type 2 diabetes mellitus: a population-level retrospective matched cohort st
    Gut. 2023 Sep 22:gutjnl-2023-329651. doi: 10.1136/gutjnl-2023-329651.
    

    >> Share

    
    July 2023
17. 
    Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg).
    Gut. 2023 Jul 19:gutjnl-2022-329259. doi: 10.1136/gutjnl-2022-329259.
    

    >> Share

    
    June 2023
18. SJOMINA O, Vangravs R, Leonova E, Polaka I, et al
    Clarithromycin-containing triple therapy for Helicobacter pylori eradication is inducing increased long-term resistant bacteria communities in the gut.
    Gut. 2023 Jun 26:gutjnl-2023-329792. doi: 10.1136/gutjnl-2023-329792.
    

    >> Share

    
    May 2023
19. ARAI J, Niikura R, Hayakawa Y, Hirata Y, et al
    Autoimmune gastritis may be less susceptible to cancer development than Helicobacter pylori-related gastritis based on histological analysis.
    Gut. 2023 May 17:gutjnl-2023-330052. doi: 10.1136/gutjnl-2023-330052.
    

    >> Share

    
    
20. LEI WY, Lee JY, Chuang SL, Bair MJ, et al
    Eradicating Helicobacter pylori via (13)C-urea breath screening to prevent gastric cancer in indigenous communities: a population-based study and development of a family index-case method.
    Gut. 2023 May 17:gutjnl-2023-329871. doi: 10.1136/gutjnl-2023-329871.
    

    >> Share

    
    April 2023
21. RALSER A, Dietl A, Jarosch S, Engelsberger V, et al
    Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature.
    Gut. 2023 Apr 4:gutjnl-2022-328075. doi: 10.1136/gutjnl-2022-328075.
    

    >> Share

    
    
22. YE BD
    Proton pump inhibitors and the risk of inflammatory bowel disease: cause, protopathic bias or others?
    Gut. 2023 Apr 4:gutjnl-2023-329506. doi: 10.1136/gutjnl-2023-329506.
    

    >> Share

    
    March 2023
23. CHEN PY, Tsai FP, Chen MJ, Yang HY, et al
    Vonoprazan-based versus proton pump inhibitor-based therapy in Helicobacter pylori eradication: an updated systematic review and meta-analysis of randomised trials.
    Gut. 2023 Mar 31:gutjnl-2023-329826. doi: 10.1136/gutjnl-2023-329826.
    

    >> Share

    
    
24. ZHANG J, Deng Y, Liu C, Wang H, et al
    'Family-based' strategy for Helicobacter pylori infection screening: an efficient alternative to 'test and treat' strategy.
    Gut. 2023 Mar 7:gutjnl-2023-329696. doi: 10.1136/gutjnl-2023-329696.
    

    >> Share

    
    
25. MALFERTHEINER P, Megraud F, Rokkas T, Gisbert JP, et al
    Empiric use of standard triple therapy in Helicobacter pylori eradication does not require readjustment in the clarithromycin resistance cut-off point.
    Gut. 2023 Mar 6:gutjnl-2023-329712. doi: 10.1136/gutjnl-2023-329712.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share